SUN PHARMACEUTICAL INDUSTRIES INC recalls buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun Pharmaceuti
Recalled May 31, 2023 · FDA recall D-0761-2023 · SUN PHARMACEUTICAL INDUSTRIES
Hazard
Failed Dissolution Specifications; during stability testing · FDA Class II
Units
5,344 Bottles
Sold at
Nationwide in the U.S.A
Description
Failed Dissolution Specifications; during stability testing
Product
buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceutical Industries Limited, Gujrat, India, NDC 47335-737-86
Manufacturer(s)
SUN PHARMACEUTICAL INDUSTRIES INC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →